1. Home
  2. Stocks
  3. Maxhealth Share Price

Max Healthcare Institute Share Price

Healthcare Large Cap

₹1,044.60 +8 (0.77%)

05 Nov, 2024 19:23

SIP TrendupStart SIP in MAXHEALTH

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹1,013
  • High
  • ₹1,050
  • 52 Week Low
  • ₹570
  • 52 Week High
  • ₹1,118
  • Open Price₹1,030
  • Previous Close₹1,037
  • Volume1,983,513

Investment Returns

  • Over 1 Month + 12.77%
  • Over 3 Month + 14%
  • Over 6 Month + 28.42%
  • Over 1 Year + 80.68%
SIP Lightning

Smart Investing Starts Here Start SIP with Max Healthcare Institute for Steady Growth!

Max Healthcare Institute Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 96.4
  • PEG Ratio
  • -9.6
  • Market Cap Cr
  • 101,549
  • P/B Ratio
  • 12.1
  • Average True Range
  • 32.84
  • EPS
  • 7.1
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 10.37
  • RSI
  • 66.77
  • MFI
  • 65.58

Max Healthcare Institute Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations621.39610.11590.75596.87543.63
Total Income From Operations621.39610.11590.75596.87543.63
P/L Before Interest, Excpt. Items & Tax210.80305.36213.33223.25174.68
P/L Before Exceptional Items & Tax203.16290.62203.33210.03160.98
P/L After Tax from Ordinary Activities154.14241.77158.12161.31126.06
Net Profit/Loss For the Period154.14241.77158.12161.31126.06
IndicatorMar 24Mar 23
Revenue From Operations [Gross]2,282.401,859.05
Revenue From Operations [Net]2,282.401,859.05
Total Operating Revenues2,341.361,904.66
Total Revenue2,612.582,048.83
Total Expenses1,747.621,485.69
Profit/Loss Before Tax864.96563.14
Profit/Loss For The Period687.26694.31
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity613.09696.47
Net Cash Used In Investing Activity-805.64-842.85
Net Cash Used in Finance Activity-245.91-54.47
Net Inc/Dec In Cash And Equivalent-438.46-200.85
Cash And Equivalent End Of Year719.2313.15
IndicatorMar 24Mar 23
Total Share Capital971.91970.92
Total Non-Current Liabilities876.07937.04
Total Current Liabilities512.04441.18
Total Capital And Liabilities9,068.878,420.33
Total Non-Current Assets8,042.116,984.28
Total Current Assets1,026.761,436.05
Total Assets9,068.878,420.33
Indicator20242023
EBIT Margin (%)39.1432.29
Return On Capital Employed (%)10.717.70
Return On Equity (%)8.949.85
Long Term Debt To Equity (%)4.086.08
Book Value/Share (INR)79.0372.53
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations1,542.951,422.901,334.971,363.161,284.99
Total Income From Operations1,542.951,422.901,334.971,363.161,284.99
P/L Before Interest, Excpt. Items & Tax345.19356.46370.92374.95322.88
P/L Before Exceptional Items & Tax321.31335.73359.68366.42303.49
P/L After Tax from Ordinary Activities236.27251.54289.34276.68240.08
Net Profit/Loss For the Period236.27251.54289.34276.68240.08
IndicatorMar 24Mar 23
Revenue From Operations [Gross]5,309.484,488.95
Revenue From Operations [Net]5,309.484,488.95
Total Operating Revenues5,406.024,562.60
Total Revenue5,584.094,701.84
Total Expenses4,218.773,638.12
Profit/Loss Before Tax1,365.321,063.72
Profit/Loss For The Period1,057.641,103.51
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity1,121.801,209.18
Net Cash Used In Investing Activity-1,285.45-1,187.01
Net Cash Used in Finance Activity-263.74-288.56
Net Inc/Dec In Cash And Equivalent-394.49-266.39
Cash And Equivalent End Of Year979.8442.75
IndicatorMar 24Mar 23
Total Share Capital971.91970.92
Total Non-Current Liabilities2,343.091,646.69
Total Current Liabilities1,248.711,045.57
Total Capital And Liabilities11,999.9410,101.85
Total Non-Current Assets10,293.768,158.78
Total Current Assets1,706.181,943.07
Total Assets11,999.9410,101.85
Indicator20242023
EBIT Margin (%)26.3625.15
Return On Capital Employed (%)13.2512.67
Return On Equity (%)12.5714.89
Long Term Debt To Equity (%)12.616.70
Book Value/Share (INR)86.5176.31

Max Healthcare Institute Technicals

EMA & SMA

Current Price
₹1,044.60
+ 8 (0.77%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹977.71
  • 50 Day
  • ₹951.35
  • 100 Day
  • ₹918.57
  • 200 Day
  • ₹855.26

Resistance and Support

1035.92 Pivot Speed
  • R3 1,095.53
  • R2 1,072.77
  • R1 1,058.68
  • S1 1,021.83
  • S2 999.07
  • S3 984.98

Is Max Healthcare Institute Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Max Healthcare Institute Ltd. is one of India’s leading healthcare providers, operating a network of multi-specialty hospitals. It offers comprehensive medical services across various specialties, including oncology, cardiology, and neurology, serving both domestic and international patients. Max Healthcare Institute has an operating revenue of Rs. 5,663.98 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 25% is great, ROE of 12% is good. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 18% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 78 which is a FAIR score but needs to improve its earnings, a RS Rating of 73 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock definitely has some strength, you may want to examine it in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Max Healthcare Institute Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-05 Quarterly Results
2024-08-01 Quarterly Results
2024-05-22 Audited Results & Final Dividend
2024-01-31 Quarterly Results
2023-11-06 Quarterly Results
Date Purpose Remarks
2024-08-23 FINAL Rs.1.50 per share(15%)Final Dividend
2023-09-08 FINAL Rs.1.00 per share(10%)Final Dividend

Max Healthcare Institute F&O

Max Healthcare Institute Shareholding Pattern

23.74%
11.56%
2.89%
57.29%
0%
3.18%
1.34%
  • NSE Symbol
  • MAXHEALTH
  • BSE Symbol
  • 543220
  • Chairman & Managing Director
  • Mr. Abhay Soi
  • ISIN
  • INE027H01010

Max Healthcare Institute FAQs

Max Healthcare Institute share price is ₹1,044 As on 05 November, 2024 | 19:09

The Market Cap of Max Healthcare Institute is ₹101548.9 Cr As on 05 November, 2024 | 19:09

The P/E ratio of Max Healthcare Institute is 96.4 As on 05 November, 2024 | 19:09

The PB ratio of Max Healthcare Institute is 12.1 As on 05 November, 2024 | 19:09

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.